Impact Factor
3.47
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.69
290 total citations
h5-index
26
h5 depth signal
Cited share
81.9%
68 of 83
Total citations
290
Citation footprint
Metric signal
3.11
External metric anchor
Self-citation
2.8%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
205
China
62
United Kingdom
53
Australia
51
Canada
35
Citing Fields of Research
Neurodegenerative Disorders
376
Psychiatry
109
Palliative Care
103
Neurosciences
45
Psychiatry & Psychology
43
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,712
Articles tracked across the journal lifetime
Indexed publication set
83
68 cited publications
Last 12 months
54
4.5 publications/month
Open access share
42.6%
23 OA publications in the last year
Leading citing country
United States
205 citing publications
Leading citing field
Neurodegenerative Disorders
376 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 1988-
v1n1, Jan. 1988-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Broad Categories
Geriatrics
Neurology
Psychiatry
Neurodegenerative Disorders
Psychiatry
Palliative Care
Neurosciences
MeSH Descriptors
Aged
Geriatric Psychiatry
Nervous System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/08919887261498437
Open DOI
Evaluating a Two-Step Approach: Combining Brief Risk Indicators and Short Cognitive Assessments for Improving Early Detection of Cognitive Impairment
Background: Scalable approaches for early detection of cognitive impairment are urgently needed. A two-step screening approach, in which short cognitive assessments are administered only to individuals at risk, offers an efficient altern...
02
DOI 10.1177/08919887261491948
Open DOI
Can Cognitive Reserve Moderate the Association Between Brain Structure and Later-Life Behavioural Symptoms?
Introduction: Cognitive reserve (CR) buffers against cognitive manifestations of neurodegenerative disease; little is known about CR and neuropsychiatric symptoms (NPS). We investigated CR moderation on the relationship between AD-relate...
03
DOI 10.1177/08919887261487671
Open DOI
Predictive Value of Abnormal Expression of miR-378a-3p in Elderly Stroke Patients for Cognitive Impairment After Stroke
Background: Post-stroke cognitive impairment (PSCI) plays an important role in recovery and quality of life in elderly stroke patients. MicroRNAs play critical roles in the pathophysiology of PSCI. Purpose: The expression of miR-378a-3p ...
04
DOI 10.1177/08919887261486060
Open DOI
Dementia Carers’ Perspectives on Paper- and Artificial Intelligence (AI)-Based Assessment Tools: A Qualitative Think-Aloud Study Using the COM-B Framework
Objectives: Carer observations provide valuable longitudinal and contextual information for dementia assessment, but traditional informant-based questionnaires may limit reporting of nuanced, fluctuating changes. Artificial intelligence ...
05
DOI 10.1177/08919887261486064
Open DOI
Mini-Mental State Examination Scores in Dementia and Capacity Assessment: A Narrative Review
Background: The Mini-Mental State Examination (MMSE) is widely used in older adults, but its numerical score is sometimes overinterpreted in dementia diagnosis and capacity assessment. This review examined the hypothesis that the MMSE pr...
06
DOI 10.1177/08919887261478290
Open DOI
Current Practice and Long-Term Developments in Multidisciplinary Dutch Memory Clinics
Objectives: Memory Clinics (MCs) have a central role in multidisciplinary diagnostics and care of cognitive disorders and dementia. This study describes current clinical practice and developments of Dutch MCs since their start in 1986. M...
07
DOI 10.1177/08919887261477071
Open DOI
Plasma Biomarkers and Clinical Indicators for Identifying Mild Cognitive Impairment in Older Adults With Psychiatric Disorders
Background: Mild Cognitive Impairment (MCI) and Mild Behavioral Impairment (MBI) can be prodromal stages of neurodegenerative disease associated with plasma biomarkers of tau pathology and neuroaxonal damage. However, in psychiatric popu...
08
DOI 10.1177/08919887261470005
Open DOI
A Systematic Review of Effects of Cholinesterase Inhibitors and Memantine on Cognitive Domains in Alzheimer’s Disease
Background: Alzheimer’s Disease (AD) is characterised by progressive cognitive decline. Cholinesterase inhibitors (ChEI) (donepezil, rivastigmine and galantamine) and memantine have been the mainstay treatment and have showed their effec...
09
DOI 10.1177/08919887261469563
Open DOI
“Has your Memory Been Letting you Down?” Use of Figurative Language Modulates Expression of Awareness of Impairments in Alzheimer’s Disease
Introduction: We compared responses of people with Alzheimer’s disease (PwAD) on the Assessment Scale of Psychosocial Impact of the Diagnosis of Dementia and an adapted figurative language version. We hypothesize that figurative language...
10
DOI 10.1177/08919887261464574
Open DOI
Identifying the Barriers and Facilitators to Clinical Implementation of Risk Prediction Tools for Dementia Across UK Primary Care: A Stakeholder Interview Study
Background: Dementia is increasingly recognised as a condition that can be prevented or delayed through modifiable lifestyle risk factors. Despite promising research into dementia risk prediction algorithms based on these risk factors, e...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 8, no. 1 (JAN 1995)19950518 Notice not published Printed on acid-free paper